DSM-FIRMENICH AG EO -,01/ CH1216478797 /
31/05/2024 7:57:40 | Diferencia +0.0500 | Volumen | Bid22:00:00 | Ask22:00:00 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
105.1000EUR | +0.05% | - Volumen de negocios: - |
104.2000Volumen de oferta: 68 | 106.4500Tamaño/ Volumen/ Formato de Ask: 68 | 28.01 mil millonesEUR | 2.37% | 11.56 |
GlobeNewswire
1:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
02/06
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
02/06
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
02/06
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
02/06
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página